Company Filing History:
1 out of 822 
1 out of 167 
Years Active: 2025
Title: Sven Stodtmann: Innovator in Pharmaceutical Formulations
Introduction
Sven Stodtmann is a notable inventor based in Neustadt an der Weinstrasse, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Parkinson's disease. His innovative approach focuses on the formulation of specific compounds that enhance therapeutic efficacy.
Latest Patents
Sven Stodtmann holds a patent for "Pharmaceutical formulations for subcutaneous administration." This patent involves compositions of levodopa 4'-monophosphate and carbidopa 4′-monophosphate, which are formulated in a weight by weight ratio of about 20:1. The methods described in this patent aim to treat Parkinson's disease and associated conditions through subcutaneous administration of these compositions. He has 1 patent to his name.
Career Highlights
Throughout his career, Sven has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with AbbVie Inc. and Abb Vie Deutschland GmbH & Co. KG. His work in these organizations has allowed him to develop and refine his innovative ideas in drug formulation.
Collaborations
Sven Stodtmann has collaborated with several professionals in his field, including Ehab Moussa and Matthew Rosebraugh. These collaborations have contributed to the advancement of his research and the successful development of his patented formulations.
Conclusion
Sven Stodtmann is a distinguished inventor whose work in pharmaceutical formulations has the potential to significantly impact the treatment of Parkinson's disease. His innovative contributions and collaborations highlight his commitment to advancing medical science.